IMPROVED HUMANIZED ANTI-HUMAN 9-INTEGRIN ANTIBODY
    1.
    发明公开
    IMPROVED HUMANIZED ANTI-HUMAN 9-INTEGRIN ANTIBODY 有权
    VERBESSERTER人类抗原抗体-MA9-INTEGRIN-ANTIKÖRPER

    公开(公告)号:EP2243829A1

    公开(公告)日:2010-10-27

    申请号:EP09700904.7

    申请日:2009-01-09

    摘要: The present invention provides a humanized anti-human α9 integrin antibody having improved activity and/or property as compared to a donor mouse anti-human α9 integrin antibody, namely, a humanized anti-human α9 integrin antibody containing a heavy-chain variable region consisting of the amino acid sequence shown by SEQ ID NO:11 and a light-chain variable region consisting of the amino acid sequence shown by SEQ ID NO:17, a humanized anti-human α9 integrin antibody containing a heavy-chain variable region consisting of the amino acid sequence shown by SEQ ID NO:13 and a light-chain variable region consisting of the amino acid sequence shown by SEQ ID NO:17, a humanized anti-human α9 integrin antibody containing a heavy-chain variable region consisting of the amino acid sequence shown by SEQ ID NO:15 and a light-chain variable region consisting of the amino acid sequence shown by SEQ ID NO:9, and a means for the prophylaxis or treatment of various diseases involving human α9 integrin in the pathogenesis, which uses the antibody.

    摘要翻译: 本发明提供与供体小鼠抗人±9整联蛋白抗体相比具有改善的活性和/或性质的人源化抗人±9整联蛋白抗体,即含有重链的人源化抗人±9整联蛋白抗体 由SEQ ID NO:11所示的氨基酸序列组成的可变区和由SEQ ID NO:17所示的氨基酸序列组成的轻链可变区,包含重链的人源化抗人±9整联蛋白抗体 由SEQ ID NO:13所示的氨基酸序列组成的可变区和由SEQ ID NO:17所示的氨基酸序列组成的轻链可变区,包含重链的人源化抗人±9整联蛋白抗体 由SEQ ID NO:15所示的氨基酸序列组成的可变区和由SEQ ID NO:9所示的氨基酸序列组成的轻链可变区,以及预防或治疗涉及人类± 9整数 rin在发病机制中,其使用抗体。